Fig. 4 ITC of duplexes with (a) unmodified C, (b) 5hmC and (c) 5mC. (a, b, c) Upper panels, data after baseline correction; Lower panels, binding
isotherms from integration. (d) Kb values (mean ꢂ s.d. of at least 2 independent expts., ESIw). Titration curves correspond to duplexes with same
modification on both strands and are representative of expts. giving the indicated Kb values. (***denotes P o 0.01).
observed within ODN sets bearing a particular modification
on the forward (groups of data bars in Fig. 4d) or reverse
strands (data bars of same colour in Fig. 4d), with the binding
constants of 5hmC-modified duplexes resembling those of
unmodified rather than methylated duplexes. In the case of
the duplex-stabilising effect of 5mC, high-level quantum
calculations suggest enhanced stacking interactions16,17
conferred by the hydrophobic methyl group may be responsible,
thus raising the possibility of the reversal of these effects by
hydroxylation.
grant [HEALTH-F4-2008-201418] READNA (A.H. E-S and
T.B.), Pfizer and the Wellcome Trust for funding. We thank
Kevin Dack for discussions.
Notes and references
y The absolute values from UVM and ITC differ, because the
techniques measure thermodynamic parameters at Tm, and at the
exptl. temp., respectively. While parameters obtained at one temp.
can be extrapolated to another, additional conformational ‘melting’
transitions of single strands occurring between these temperature need
to be taken into account, precluding direct quantitative comparison.
z Table S3 gives data for titrations/accuracy of parameter fitting;
Table S4 gives data for group averages of all unique combinations of
C/5hmC/5mC duplexes.
Overall, the combined analyses reveal the potential of 5mC
hydroxylation to, at least in part, reverse the thermodynamic
duplex stabilisation conferred by 5mC in multiple sequence
contexts, without a requirement for demethylation or further
modification. Although the roles of proteins in the regulation
of transcription have been extensively studied, to our knowledge
the effect that methylation has ‘directly’ on DNA duplex
stability has not been widely considered as a contributing
factor in transcriptional regulation. With all other factors
being equal, our results lead to the proposal that 5mC
hydroxylation is more likely associated with transcriptional
activation than repression (Fig. 1b). Consistent with our
proposal, two recent studies have associated TET activity with
transcriptional activation.18,19 Of course, as for 5mC, the
effects of 5hmC may be differentially manifested in the
presence of additional factors, including, for example,
DNA-binding20 proteins such the CXXC domains which are
part of the TET enzymes.18 Given the established regulatory
role of chromatin structure on transcription, TET-catalysed
5mC-hydroxylation of CpG islands in promoter regions of
transcriptionally inactive genes could act to reduce duplex
stability, facilitate strand separation or alleviate 5mC-con-
trolled transcriptional repression by enabling recruitment of
transcriptional machinery. Finally, given the role of the
hypoxia inducible factor 2OG-dependent hydroxylases in the
oxygen dependent regulation of transcription, it is possible
that the 5hmC formation represents a mechanism for oxygen
dependent regulation of expression, including in an epigenetic
manner.
1 J. T. Attwood, R. L. Yung and B. C. Richardson, Cell. Mol. Life
Sci., 2002, 59, 241–257.
2 A. Portela and M. Esteller, Nat. Biotechnol., 2010, 28, 1057–1068.
3 M. Esteller, Hum. Mol. Genet., 2007, 16, R50–59.
4 S. Kriaucionis and N. Heintz, Science, 2009, 324, 929–930.
5 M. Tahiliani, K. P. Koh, Y. Shen, W. A. Pastor, H. Bandukwala,
Y. Brudno, S. Agarwal, L. M. Iyer, D. R. Liu, L. Aravind and
A. Rao, Science, 2009, 324, 930–935.
6 S. Ito, A. C. D’Alessio, O. V. Taranova, K. Hong, L. C. Sowers
and Y. Zhang, Nature, 2010, 466, 1129–1133.
7 U. Bacher, C. Haferlach, S. Schnittger, A. Kohlmann, W. Kern
and T. Haferlach, Ann. Hematol., 2010, 89, 643–652.
8 U. Bacher, S. Schnittger and T. Haferlach, Curr. Opin. Oncol.,
2010, 22, 646–655.
9 M. A. McDonough, C. Loenarz, R. Chowdhury, I. J. Clifton and
C. J. Schofield, Curr. Opin. Struct. Biol., 2010, 20, 659–672.
10 L. E. Xodo, G. Manzini, F. Quadrifoglio, G. A. van der Marel and
J. H. van Boom, Nucleic Acids Res., 1991, 19, 5625–5631.
11 H. H. Klump and R. Loffler, Biol. Chem. Hoppe-Seyler, 1985, 366,
345–353.
12 D. J. Prockop and K. I. Kivirikko, Annu. Rev. Biochem., 1995, 64,
403–434.
13 A. P. Hardy, I. Prokes, L. Kelly, I. D. Campbell and
C. J. Schofield, J. Mol. Biol., 2009, 392, 994–1006.
14 A. S. Hansen, A. Thalhammer, A. H. El-Sagheer, T. Brown and
C. J. Schofield, Bioorg. Med. Chem. Lett., 2011, 21, 1181–1184.
15 C. M. R. Lopez, B. G. Asenjo, A. J. Lloyd and M. J. Wilkinson,
Anal. Chem., 2010, 82, 9100–9108.
16 C. Acosta-Silva, V. Branchadell, J. Bertran and A. Oliva, J. Phys.
Chem. B, 2010, 114, 10217–10227.
17 N. Tretyakova, R. Guza and B. Matter, Nucleic Acids Symp. Ser.,
2008, 52, 49–50.
18 S. Ito, A. C. D’Alessio, O. V. Taranova, K. Hong, L. C. Sowers
and Y. Zhang, Nature, 2010, 466, 1129–1133.
19 H. Zhang, X. Zhang, E. Clark, M. Mulcahey, S. Huang and
Y. G. Shi, Cell Res., 2010, 20, 1390–1393.
20 V. Valinluck, H.-H. Tsai, D. K. Rogstad, A. Burdzy, A. Bird and
L. C. Sowers, Nucleic Acids Res., 2004, 32, 4100–4108.
We thank the Biotechnology and Biological Sciences
Research Council, Cancer Research UK (to A.T.), the European
Community’s 7th Framework Programme [FP7/2007-2013]
c
This journal is The Royal Society of Chemistry 2011
Chem. Commun., 2011, 47, 5325–5327 5327